Mr. Speaker, the international community on August 30 agreed that countries could provide for generic manufacture for export to Africa and other places where the need exists.
Yesterday, 68 days after that agreement, we tabled this legislation. That is a result of a deep commitment on the part of the Prime Minister and this government to make sure that we make affordable drugs available in Africa and elsewhere where they are needed.
Groups such as the Canadian HIV/AIDS Legal Network are asking that we go through second reading and get this bill to committee right away so we can look at it carefully. That is what we want to do. If the member has constructive suggestions to make about improving the bill, I hope she will make those points at committee.